IRVINE, Calif.–(BUSINESS WIRE)–Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat, today announced that it has completed enrollment of the...
The 4th Annual Global Clinical Trials Connect 2020 will provide a platform to discuss on the futuristic advancements in clinical trials and clinical research. This multidisciplinary program involves broad participation of people from clinical trials community from...
Biopharma company Atrin Pharmaceuticals, a drug discovery and development company focused on molecules targeting DNA damage and repair (DDR) pathways to treat cancer, and gene-based analytics company Predictive Technology Group say they have successfully tested a...
TAMPA, FL / ACCESSWIRE / February 26, 2020 / GT Biopharma, Inc. (OTCQB:GTBP)(GTBP.PA) an immuno-oncology company focused on innovative treatments based on the Company’s proprietary NK cell engager (TriKE™) platform announced today that the first patient has been...
The new law aims to enhance patient participation and retention in cancer clinical trials. Credit: Ernesto Eslava from Pixabay. Illinois lawmakers have introduced new legislation called SB1711, the Clinical Trial Participation Act, that gives all cancer patients...
REDWOOD CITY, Calif., Feb. 26, 2020 (GLOBE NEWSWIRE) — Menlo Therapeutics Inc. (Nasdaq: MNLO), a late-stage biopharmaceutical company, today announced results from its Phase 2 clinical trial evaluating the safety and efficacy of once daily oral serlopitant for...
Email
Text